UBQLN4 and cancer: To explore the potential utility of UBQLN4 as a predictive marker for drug sensitivity in pan-cancer, we examined the association between UBQLN4 mRNA expression and drug sensitivity using the combined datasets of CCLE and Profiling Relative Inhibition Simultaneously in Mixtures (PRISM) Repurposing Secondary Screen datasets [21].